Generating pluripotent stem cells directly from somatic cells obtained from patients is one of the major methods to avoid tissues rejection in regenerative medicine. Beside somatic cell nuclear transfer, recent studies have shown that human embryonic stem cells (hESCs) have the ability to reprogram somatic cells after fusion by PEG. But the low efficiency of PEG induced fusion in the study might be one of the obstacles for the technology to be used practically. Electrofusion is a biomedically safe method that has been broadly used in nuclear transfer. This study is to investigate whether electrofusion would improve the fusion efficiency of hESCs with human embryonic fibroblasts (HEFs). A normal hESC line with 46, XX karyotype and a HEF line with 46, XY karyotype were used in this study. Before electrofusion, both of the cells were dissociated into single cells and were separately labeled by DIO and DID. 
